considering specific studies for asymptomatic patients.
Recent progress in medical technology enables non-invasive measurement of arterial stiffness. An increase in arterial stiffness suggests the presence of cardiovascular diseases [3] [4] [5] . Pulse wave velocity and the augmentation index are common examples; however, both arterial stiffness parameters are affected by blood pressure, and blood pressure abnormality is very common among patients with chronic kidney diseases 6) . It would be preferable to have a parameter that measures arterial stiffness non-invasively and independently of blood pressure as a screening test to detect cardiovascular diseases in patients with chronic kidney diseases.
The stiffness parameter appears suited to these demands.
Methods
Patients who visited our clinics were enrolled in the study after giving informed consent. All patients
Introduction
Chronic kidney disease is an established risk factor for cardiovascular diseases 1) . Cardiovascular disease is a major cause of death in patients with chronic kidney diseases 2) ; however, concomitant conditions such as bone-joint diseases and/or renal anemia cause patients with chronic kidney diseases to have reduced exercise tolerability, masking the symptoms of cardiovascular diseases. Extensive investigations into the presence of cardiovascular diseases are not allowed for patients with chronic kidney diseases, mainly due to socio-economical problems. A screening test is mandatory to screen for the presence of cardiovascular diseases before received maintenance hemodialysis three days a week, 4 hours each session. Edema-free dry weight was carefully determined for individual patients, taking blood pressure, cardiothorathic ratio, atrial natriuretic peptide level and echocardiographic findings (end-diastolic left ventricular diameter and vena cava diameter) into consideration 7, 8) . Initially, stiffness parameter was defined as the blood pressure-independent local stiffness of blood vessels, based on a change in vascular diameter corresponding to arterial pressure variance. The was defined as In(Ps/Pd) D/ D, provided that Ps, Pd and D described systolic pressure, diastolic pressure and diameter. The cardio-ankle vascular index (CAVI) was applied the for the arterial tree from the ascending aorta to the tibial artery. Bramwell-Hill formula expresses the relation between volume elastic modulus and pulse wave velocity (PWV); PWV 2 P/ V/ V, where , P and V indicate blood density, pressure and
in which L and D indicate the length and diameter of the vessel. CAVI In(Ps/Pd) 2 / P PWV 2 9) . CAVI was measured after a hemodialysis session as the patient had a stable dry weight 10) . All CAVI measurements were performed with VaSera (Fukuda Denshi Co Ltd, Tokyo) from September to November 2006. Cuffs were placed on both ankles and a brachium, which was not used for blood access. PWV was obtained by dividing vascular length by the time taken for the pulse wave to travel from the aortic valve to the ankle 3) . Brachial-ankle PWV well correlated to aortic PWV 11) . To detect arterial waves with cuffs, cuff pressure was kept low at 30 to 50 mmHg to ensure a small effect of cuff pressure on hemodynamics, including reflection 9) . Blood pressure was measured thereafter, and the ankle brachial pressure index (ABI) was calculated. PWV is falsely low when ABI is lower than 0.9 3) . Patients showing an ABI lower than 0.9 were excluded from CAVI analysis. The coefficient of variation of CAVI was 3.8%, which is small enough for clinical usage 9) . Blood samples were taken after overnight fast to measure lipid profiles, including total cholesterol, high density lipoprotein cholesterol and triglyceride. Diabetes was diagnosed by medical history and/or biochemical data, including 75 g oral glucose tolerance test if necessary. For diabetic patients, fasting plasma glucose and HbA1c were also measured. Cardiovascular diseases constitute coronary artery disease (a history of myocardial infarction or coronary intervention, or angina pectoris with coronary artery stenosis (more than 75%) confirmed angiographically), cerebral artery disease (a history of stroke, the presence of cerebral diseases confirmed by CT scan or MRI, carotid artery stenosis (more than 75%) by ultrasonography) and peripheral artery disease (confirmed by MRA or angiography). Peripheral artery diseases were diagnosed when stenosis more than 75% was seen in the large artery (iliac or femoral artery) and/or when one or two arteries were occluded below the knee.
Data are expressed as the means SD, unless otherwise stated. Statistical analyses were carried out using stepwise, multivariate and simple regression analyses, Student's t tests and the receiver operation characteristic (ROC) curve. P 0.05 was considered significant.
Results
Sixty-eight patients save informed consent and entered the study, 15 females and 53 males. Twentyfive of the 68 patients were diabetics. Although HbA1c for 25 diabetes was 5.9 0.4% and fasting plasma glucose was 105 6 mg/dL, ABI in diabetes (0.97 0.03, n 25) was lower than in non-diabetic patients (1.08 0.02, n 43, p 0.05). In addition, 6 diabetic and 4 non-diabetic patients exhibited ABI lower than 0.9. Thus, 10 patients showed ABI lower than 0.9, and they were excluded from CAVI analysis. Table 1 summarizes the background of 58 patients with ABI over 0.9.
Stepwise regression analysis between CAVI and patient backgrounds was performed. Patient back- grounds included age, height, weight, hemodialysis duration, pulse rate, lipid profiles, the presence of diabetes or cardiovascular diseases, systolic and diastolic blood pressure. As shown in Table 2 , both age and the presence of cardiovascular disease were chosen to account for an increase in CAVI. Among patients with cerebral arterial disease, only one patient showed severe carotid arterial stenosis (90%) without a history of stroke or obvious cerebral lesion by image study, supporting the notion that arterial stenosis more than 75% is suitable to assess clinically significant cardiovascular risk.
Simple regression analysis was performed to show a positive relationship between age and CAVI (Fig. 1) . thus, multivariate regression analysis between CAVI and patient backgrounds indicated that age, the presence of diabetes and cardiovascular disease constituted independent contributors to CAVI ( Table 3) . Furthermore, Fig. 2 revealed that CAVI was elevated in patients with a history of cardiovascular diseases (8.69 0.23, n 34) than in those without (6.66 0.28, n 24, p 0.01). As expected, patients positive for cardiovascular diseases (64 2 y/o) were older than those without (52 2 y/o, p 0.05). In addition, CAVI was higher in diabetics (8.39 0.37, n 19) than nondiabetics (7.63 0.57, n 39, p 0.05), as shown in Fig. 3 . Of interest, diabetic patients (56 3 y/o) tended Finally, ROC curve analysis was performed to assess the cut-off value of CAVI to detect the presence of cardiovascular diseases (Fig. 4) . The analysis determined that patients with CAVI over 7.55 possess cardiovascular diseases with both sensitivity and specificity of 79%.
Discussion
An original stiffness parameter is independent of blood pressure; thus, CAVI is also theoretically independent of blood pressure 9) . Furthermore, CAVI correlated with the original parameter and the intimamedia thickness of the carotid artery 12) . Shirai et al. reported that CAVI correlated to systolic blood pressure in hemodialysis patients, and that the contribution of blood pressure to CAVI was much smaller than PWV 9) . In the present study, although the possibility remained that the number of patients enrolled was too small to detect a relation, neither stepwise nor multivariate regression analysis showed a significant relation between CAVI and either systolic or diastolic blood pressure. Taken together, these findings suggest that CAVI is an arterial stiffness parameter relatively independent of blood pressure in this patient population.
Cardiovascular aging is an important issue in the focus of extensive investigations. Arterial stiffness is closely related to cardiovascular aging. Patients with chronic kidney disease show the elevation of arterial stiffness, as an expression of premature vascular aging. The present study provided the first evidence that CAVI correlates to age in hemodialysis patients. After examining individuals who came for a health check up, Kubozono et al. reported that CAVI progressively increased as subjects aged 13) ; thus, CAVI can assess cardiovascular aging in patients with chronic kidney diseases as well as without renal diseases.
The presence of diabetes worsens patient prognosis, partly due to the early development of atherosclerotic cardiovascular diseases, including coronary and peripheral artery diseases. Consistent with our previous results 7, 14) , the present data demonstrated that ABI was lower in diabetics than non-diabetics. We recently reported that hemodialysis patients exhibiting ABI lower than 0.9 suffered more cardiovascular events 7) . Furthermore, our current findings indicated that CAVI was higher in diabetics than non-diabetics, however, stepwise regression failed to select diabetes as a significant contributor to CAVI. Many diabetic patients with advanced atherosclerosis dropped out of the CAVI analysis due to low ABI, which suggests the presence of peripheral artery disease, a cardiovascular disease. Alternatively, multivariate regression highrighted diabetes as an independent contributor to CAVI. In the present study, multivariate regression analysis showed the tendency for a positive correlation of CAVI to height, and an inverse relation to weight. This is compatible with the epidemiological paradox that higher BMI is associated with better prognosis in hemodialysis patients 15) . Collectively, these observations suggest that CAVI is useful as an indicator of arterial stiffness, a character of atherosclerosis, for patients with ABI over 0.9, and raises the possibility that CAVI predicts patient prognosis, as does PWV 3, 16) , although the conclusion awaits a prospective study.
CAVI may become a useful screening test to detect cardiovascular diseases. Patients with chronic kidney diseases frequently suffer orthopedic diseases, partly due to calcium-phosphate disturbance 8) . Renal anemia also limits the activity of daily life 17) . These concomitant conditions prevent patients from making efforts sufficient to induce symptoms. Our data indicate that any patient with CAVI over 7.55 has cardiovascular disease with both sensitivity and specificity of 0.79. CAVI would motivate asymptomatic patients to undergo tests. Using ROC analysis, Covic et al. reported that PWV (sensitivity 0.77, specificity 0.60) and AI (sensitivity 0.87, specificity, 0.70) can predict coronary artery diseases in patients with chronic kidney diseases 18) . Although direct comparison is difficult, PWV and AI may show lower specificity than CAVI. A caveat merits comments. The present data demonstrated that CAVI elevated as age increased, however, the above criteria did not take age into consideration, and may automatically select elderly people aspositive for cardiovascular diseases, although diabetic patients manifesting higher CAVI were rather younger than those without diabetes. In addition, stepwise as well as multivariate regression analyses selected both age and the presence of cardiovascular disease as independent positive contributors to CAVI. While further large scale studies are required before applying a cutoff point for the general population, our data suggest that a hemodialysis patient with high CAVI should receive specific tests to detect silent cardiovascular diseases.
